In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all educational programs.
The following faculty have disclosed:
Marius Hoeper, MD, faculty for this educational event, receives consulting fees from Acceleron, Actelion, AOP Health, Bayer, Ferrer, GSK, Janssen, and MSD.
Steven Nissen, MD, MACC, faculty for this educational event, receives research funds from Abbvie, AstraZeneca, Amgen, Bristol Myers Squibb, Eli Lilly, Esperion, Medtronic, MyoKardia, New Amsterdam Pharmaceuticals, Novartis, Pfizer, and Silence Therapeutics.
Kelly Chin, MD, faculty for this educational event, receives research funds from Acceleron, Altavant, Gossamer Bio, Janssen, Merck, Pfizer and United Therapeutics; and receives consulting fees from Arena, Acceleron and Shouti.
Christie Mitchell Ballantyne, MD, faculty for this educational event, receives research funds from Abbott Diagnostic, Akcea, Amgen, Arrowhead, Esperion, Ionis, Merck, New Amsterdam, Novartis, Novo Nordisk, Regeneron, and Roche Diagnostic; and receives consulting fees from 89Bio, Abbott Diagnostics, Alnylam
Pharmaceuticals, Althera, Amarin, Amgen, Arrowhead, Astra Zeneca, Denka Seiken, Esperion, Genentech, Gilead, Illumina, Matinas, BioPharma Inc, Merck, New Amsterdam, Novartis, Novo Nordisk, Pfizer, Regeneron, and Roche Diagnostic.
R. Kevin Rogers, MD, MSc, RPVI, faculty for this educational event, has no relevant financial relationships with ineligible companies.
Marc P. Bonaca, MD, MPH, FAHA, FACC, faculty for this educational event, receives research funds from Abbott Laboratories, Adamis Pharmaceuticals Corporation, Agios Pharmaceuticals, Inc., Alexion Pharma, Alnylam Pharmaceuticals, Inc., Amgen Inc., Angionetics, Inc., ARCA Biopharma, Inc., Array BioPharma, Inc., AstraZeneca and Affiliates, Atentiv LLC, Audentes Therapeutics, Inc., Bayer and Affiliates, Beth Israel Deaconess Medical Center, Better Therapeutics, Inc., BIDMC, Boston Clinical Research Institute, Bristol-Meyers Squibb Company, Cambrian Biopharma, Inc., Cardiol Therapeutics Inc., CellResearch Corp., Cook Medical Incorporated, Covance, CSL Behring LLC, Eidos Therapeutics, Inc., EP Trading Co. Ltd., EPG Communication Holdings Ltd., Epizon Pharma, Inc., Esperion Therapeutics, Inc., Everly Well, Inc., Exicon Consulting Pvt. Ltd., Faraday Pharmaceuticals, Inc., Foresee Pharmaceuticals Co. Ltd., Fortress Biotech, Inc., HDL Therapeutics Inc., HeartFlow Inc., Hummingbird Bioscience, Insmed Inc., Ionis Pharmaceuticals, IQVIA Inc., JanOne Biotech Holdings Inc., Janssen and Affiliates, Kaneka, Kowa Research Institute, Inc., Kyushu University, Lexicon Pharmaceuticals, Inc., LSG Kyushu University, Medimmune Ltd., Medpace, Merck & Affiliates, Novartis Pharmaceuticals Corp., Novate Medical, Ltd., Novo Nordisk, Inc., Pan Industry Group, Pfizer Inc., PhaseBio Pharmaceuticals, Inc., PPD Development, LP, Prairie Education and Research Cooperative, Prothena Biosciences Limited, Regeneron Pharmaceuticals, Inc., Regio Biosciences, Inc., Rexgenero, Sanifit Therapeutics S.A., Sanofi-Aventis Groupe, Silence Therapeutics PLC, Smith & Nephew plc, Stealth BioTherapeutics Inc., State of Colorado CCPD Grant, The Brigham & Women's Hospital, Inc., The Feinstein Institutes for Medical Research, Thrombosis Research Institute, University of Colorado, University of Pittsburgh, VarmX, Virta HealthCorporation, WCT Atlas, Worldwide Clinical Trials Inc., WraSer, LLC,Yale Cardiovascular Research Group, and AHA SFRN; receives consulting fees from Audentes; and has an ownership interest in Medtronic and Pfizer.
Marat Fudim, MD, MHS, faculty for this educational event, receives consulting fees from Merck.
Cynthia M. Westerhout, PhD, faculty for this educational event, receives consulting fees from Bayer Canada.
Stephen J. Greene, MD, FACC, FHFSA, faculty for this educational event, receives research funds from AstraZeneca, Amgen, Cytokinetics, Pfizer, Merck, Novartis, Sanofi, Bristol Myers Squibb; and receives consulting fees from AstraZeneca, Amgen, Bayer, Boehringer Ingelheim, Cytokineteics, Merck, PharmaIN, Roche Diagnostics, Sanofi, Tricog Health, Urovant Pharmaceuticals, CSL Vifor and scPharmaceuticals.
Ahmad Masri, MD, MS, faculty for this educational event, receives research funds from Pfizer, Ionis/Akcea, Attralus, Cytokinetics, Ultromics and the Wheeler Foundation; and receives consulting fees from Cytokinetics, BMS, Eidos, Pfizer, Ionis, Lexicon, Alnylam, Attralus, Haya, Intellia and Tenaya.